Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
To evaluate the effects of this LNG/EE combination on bleeding profile, endometrial histology, hemostasis measures, hemoglobin levels, discontinuation rates, subject satisfaction, and cycle-related symptoms and work productivity at baseline.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 49 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Healthy women aged 18 to 49 years
Regular (21- to 35- day) menstrual cycles for the 3-month period preceding visit 1
Must be sexually active and at risk for becoming pregnant.
Planned use of any other form of birth control other than the test article.
Depression requiring hospitalization or associated with suicidal ideation within the last 3 years.
High blood pressure (defined as elevated sitting blood pressure: > 140/90 mm Hg).